Reply

Affiliations

¹ Royal Free Hospital, London, UK.
² University of Manchester Salford Royal NHS Foundation Trust, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Comment

Christopher P Denton et al. Arthritis Rheumatol. 2018 Jun.

. 2018 Jun;70(6):974.

doi: 10.1002/art.40480. Epub 2018 May 2.

¹ Royal Free Hospital, London, UK.
² University of Manchester Salford Royal NHS Foundation Trust, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

No abstract available

Comment on

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.
Denton CP, Hachulla É, Riemekasten G, Schwarting A, Frenoux JM, Frey A, Le Brun FO, Herrick AL; Raynaud Study Investigators. Denton CP, et al. Arthritis Rheumatol. 2017 Dec;69(12):2370-2379. doi: 10.1002/art.40242. Arthritis Rheumatol. 2017. PMID: 29193819 Free PMC article. Clinical Trial.
Patient Perceptions of the Raynaud's Condition Score Diary Provide Insight Into Its Performance in Clinical Trials of Raynaud's Phenomenon: Comment on the Article by Denton et al.
Pauling JD, Saketkoo LA, Domsic RT. Pauling JD, et al. Arthritis Rheumatol. 2018 Jun;70(6):973-974. doi: 10.1002/art.40481. Epub 2018 Apr 29. Arthritis Rheumatol. 2018. PMID: 29513932 No abstract available.